Laxminarayan Bhat
Founder at REVIVA PHARMACEUTICALS HOLDINGS, INC.
Net worth: 9 M $ as of 30/03/2024
Profile
Laxminarayan Bhat founded Reviva Pharmaceuticals, Inc. in 2006, where he is working as President, Chief Executive Officer & Director from 2006 and Reviva Pharmaceuticals Holdings, Inc. in 2020, where he is working as President, Chief Executive Officer & Director from 2020.
Dr. Bhat received his doctorate degree from North-Eastern Hill University.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
28/09/2023 | 2,484,244 ( 8.90% ) | 9 M $ | 30/03/2024 |
Laxminarayan Bhat active positions
Companies | Position | Start |
---|---|---|
REVIVA PHARMACEUTICALS HOLDINGS, INC. | Founder | 10/12/2020 |
Reviva Pharmaceuticals, Inc.
Reviva Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Reviva Pharmaceuticals, Inc. operates as a clinical stage development pharmaceutical company. The firm develops various therapies using chemical genomics for treatment of central nervous system, cardiovascular, metabolic and inflammatory diseases. The company was founded by Laxminarayan Bhat in 2006 and is headquartered in Cupertino, CA. | Founder | 31/12/2005 |
Training of Laxminarayan Bhat
North-Eastern Hill University | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
REVIVA PHARMACEUTICALS HOLDINGS, INC. | Health Technology |
Private companies | 1 |
---|---|
Reviva Pharmaceuticals, Inc.
Reviva Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Reviva Pharmaceuticals, Inc. operates as a clinical stage development pharmaceutical company. The firm develops various therapies using chemical genomics for treatment of central nervous system, cardiovascular, metabolic and inflammatory diseases. The company was founded by Laxminarayan Bhat in 2006 and is headquartered in Cupertino, CA. | Health Technology |
- Stock Market
- Insiders
- Laxminarayan Bhat